BIRC5 and cancer: STAT3’s target genes are mainly implicated in processes of cell differentiation, such as survivin (BIRC5), B-cell lymphoma (Bcl)-2, cyclin D1, c-Myc or vascular endothelial growth factor (VEGF), thus their expression plays a key role in cancer promotion (57–61).